Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -0.74% is 89% above its 5-year average of -6.79%, near the high end of its 5-year range (-77.00%–3.77%).
62.32% above its 12-month average of -1.96%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 3.77%.
NET PROFIT MARGIN
-0.74%
NET PROFIT MARGIN AVG TTM
-1.96%
NET PROFIT MARGIN AVG 3Y
-4.56%
NET PROFIT MARGIN AVG 5Y
-6.79%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+62.32%
CURRENT VS 3Y AVG
+83.76%
CURRENT VS 5Y AVG
+89.10%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 726 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Clover Health Investments, Corp.
Market Cap
$2.40B
Net Profit Margin
-0.74%
TTM Avg
-1.96%
3Y Avg
-4.56%
5Y Avg
-6.79%
Market Cap
$2.39B
Net Profit Margin
32.98%
TTM Avg
37.58%
3Y Avg
5.36%
5Y Avg
-41.08%
Market Cap
$2.39B
Net Profit Margin
-40.18%
TTM Avg
-20.09%
3Y Avg
-20.09%
5Y Avg
-20.09%
Market Cap
$2.37B
Net Profit Margin
-928.44%
TTM Avg
-334.88%
3Y Avg
-330.91%
5Y Avg
-326.71%
Market Cap
$2.42B
Net Profit Margin
-945.92%
TTM Avg
-825.68%
3Y Avg
-750.64%
5Y Avg
-1236.10%
Market Cap
$2.35B
Net Profit Margin
30.74%
TTM Avg
-487.59%
3Y Avg
-420.36%
5Y Avg
-1671.77%
Market Cap
$2.44B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.30B
Net Profit Margin
18.88%
TTM Avg
19.31%
3Y Avg
25.55%
5Y Avg
15.07%
Market Cap
$2.27B
Net Profit Margin
-37.07%
TTM Avg
-63.15%
3Y Avg
-35.64%
5Y Avg
-15.45%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Clover Health Investments, Corp. (CLOV) | $2.40B | -0.74% | -1.96% | -4.56% | -6.79% |
| ADMA Biologics, Inc. (ADMA)vs › | $2.39B | 32.98% | 37.58% | 5.36% | -41.08% |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.39B | -40.18% | -20.09% | -20.09% | -20.09% |
| Nurix Therapeutics, Inc. (NRIX)vs › | $2.37B | -928.44% | -334.88% | -330.91% | -326.71% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.42B | -945.92% | -825.68% | -750.64% | -1236.10% |
| Liquidia Corporation (LQDA)vs › | $2.35B | 30.74% | -487.59% | -420.36% | -1671.77% |
| Disc Medicine, Inc. (IRON)vs › | $2.44B | 0.00% | 0.00% | 0.00% | 0.00% |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.30B | 18.88% | 19.31% | 25.55% | 15.07% |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.27B | -37.07% | -63.15% | -35.64% | -15.45% |
| Privia Health Group, Inc. (PRVA)vs › | $2.58B | 1.19% | 0.96% | 0.67% | -2.16% |
Operating Margin
-0.7%
Net Profit Margin
-0.7%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 3.77% |
| 2026-03-31 | 3.65% |
| 2025-12-31 | -10.11% |
| 2025-09-30 | -4.91% |
| 2025-06-30 | -2.21% |
| 2025-03-31 | -0.28% |
| 2024-12-31 | -6.56% |
| 2024-09-30 | -2.77% |
| 2024-06-30 | 2.08% |
| 2024-03-31 | -5.53% |
| 2023-12-31 | -13.81% |
| 2023-09-30 | -13.55% |
| 2023-06-30 | -9.00% |
| 2023-03-31 | -22.55% |
| 2022-12-31 | -9.35% |
| 2022-09-30 | -8.81% |
| 2022-06-30 | -12.33% |
| 2022-03-31 | -8.63% |
| 2021-12-31 | -43.33% |
| 2021-09-30 | -8.08% |
| 2021-06-30 | -77.00% |
| 2021-03-31 | -24.17% |
| 2020-12-31 | -76.03% |
| 2020-09-30 | 7.55% |
| 2020-06-30 | 3.14% |
| 2020-03-31 | -17.02% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | -43.64% |
| 2019-06-30 | -98.98% |
| 2019-03-31 | -98.98% |
